XLYNX Materials announced a pioneering breakthrough in the direct photopatterning of colloidal quantum dots (QDs), addressing long-standing challenges in resolution, scalability, and material ...

Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, announced that its wholly owned subsidiary, Algernon NeuroScience (AGN Neuro), has appointed Validcare as ...